Stephen H. Safe
Corresponding Author: Stephen Safe
Department of Veterinary Physiology and Pharmacology
Texas A&M University
4466 TAMU
Name/email consistency: high
- Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters. Kim, K., Chadalapaka, G., Pathi, S.S., Jin, U.H., Lee, J.S., Park, Y.Y., Cho, S.G., Chintharlapalli, S., Safe, S. Mol. Cancer Ther. (2012)
- Aryl Hydrocarbon Receptor (AHR)-Active Pharmaceuticals Are Selective AHR Modulators in MDA-MB-468 and BT474 Breast Cancer Cells. Jin, U.H., Lee, S.O., Safe, S. J. Pharmacol. Exp. Ther. (2012)
- Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer. Liu, X., Jutooru, I., Lei, P., Kim, K., Lee, S.O., Brents, L.K., Prather, P.L., Safe, S. Mol. Cancer Ther. (2012)
- Aryl Hydrocarbon Receptor Agonists Induce MicroRNA-335 Expression and Inhibit Lung Metastasis of Estrogen Receptor Negative Breast Cancer Cells. Zhang, S., Kim, K., Jin, U.H., Pfent, C., Cao, H., Amendt, B., Liu, X., Wilson-Robles, H., Safe, S. Mol. Cancer Ther. (2012)
- Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent. Sreevalsan, S., Joseph, S., Jutooru, I., Chadalapaka, G., Safe, S.H. Anticancer Res. (2011)
- Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. Chintharlapalli, S., Papineni, S., Lei, P., Pathi, S., Safe, S. BMC. Cancer (2011)
- 3-methylcholanthrene induces differential recruitment of aryl hydrocarbon receptor to human promoters. Safe, S. Toxicol. Sci. (2010)
- Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs. Safe, S., Papineni, S., Chintharlapalli, S. Cancer Lett. (2008)
- Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. Safe, S., Kim, K., Kim, K. J. Mol. Endocrinol. (2008)
- The role of xenoestrogenic compounds in the development of breast cancer. Safe, S., Papineni, S. Trends Pharmacol. Sci. (2006)
- Clinical correlates of environmental endocrine disruptors. Safe, S. Trends Endocrinol. Metab. (2005)
- Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Abdelrahim, M., Safe, S. Mol. Pharmacol. (2005)
- Sp transcription factor family and its role in cancer. Safe, S., Abdelrahim, M. Eur. J. Cancer (2005)
- Endocrine disruptors and human health: is there a problem. Safe, S. Toxicology (2004)
- Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Safe, S., Wormke, M. Chem. Res. Toxicol. (2003)
- Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers (Review). Safe, S., McDougal, A. Int. J. Oncol. (2002)
- Environmental estrogens: roles in male reproductive tract problems and in breast cancer. Safe, S. Rev. Environ. Health (2002)
- Problems for risk assessment of endocrine-active estrogenic compounds. Safe, S.H., Pallaroni, L., Yoon, K., Gaido, K., Ross, S., McDonnell, D. Environ. Health Perspect. (2002)
- Molecular biology of the Ah receptor and its role in carcinogenesis. Safe, S. Toxicol. Lett. (2001)
- Toxicology of environmental estrogens. Safe, S.H., Pallaroni, L., Yoon, K., Gaido, K., Ross, S., Saville, B., McDonnellc, D. Reprod. Fertil. Dev. (2001)
- Bisphenol A and related endocrine disruptors. Safe, S. Toxicol. Sci. (2000)
- Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells. Safe, S., Wormke, M., Samudio, I. J. Mammary. Gland. Biol. Neoplasia (2000)
- Symposium on mechanisms of action of naturally occurring anticarcinogens. Safe, S., Wargovich, M.J., Lamartiniere, C.A., Mukhtar, H. Toxicol. Sci. (1999)
- Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer. Safe, S., Qin, C., McDougal, A. Expert. Opin. Investig. Drugs (1999)
- Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Safe, S., Wang, F., Porter, W., Duan, R., McDougal, A. Toxicol. Lett. (1998)
- Methods for xenoestrogen testing. Safe, S., Connor, K., Gaido, K. Toxicol. Lett. (1998)
- Interactions between hormones and chemicals in breast cancer. Safe, S.H. Annu. Rev. Pharmacol. Toxicol. (1998)
- Estrogen- and antiestrogen-responsiveness of HEC1A endometrial adenocarcinoma cells in culture. Castro-Rivera, E., Safe, S. J. Steroid Biochem. Mol. Biol. (1998)
- Is there an association between exposure to environmental estrogens and breast cancer?. Safe, S.H. Environ. Health Perspect. (1997)